472 related articles for article (PubMed ID: 26516769)
1. Receptor, Ligand and Transducer Contributions to Dopamine D2 Receptor Functional Selectivity.
Peterson SM; Pack TF; Caron MG
PLoS One; 2015; 10(10):e0141637. PubMed ID: 26516769
[TBL] [Abstract][Full Text] [Related]
2. Elucidation of G-protein and β-arrestin functional selectivity at the dopamine D2 receptor.
Peterson SM; Pack TF; Wilkins AD; Urs NM; Urban DJ; Bass CE; Lichtarge O; Caron MG
Proc Natl Acad Sci U S A; 2015 Jun; 112(22):7097-102. PubMed ID: 25964346
[TBL] [Abstract][Full Text] [Related]
3. The dopamine D2 receptor can directly recruit and activate GRK2 without G protein activation.
Pack TF; Orlen MI; Ray C; Peterson SM; Caron MG
J Biol Chem; 2018 Apr; 293(16):6161-6171. PubMed ID: 29487132
[TBL] [Abstract][Full Text] [Related]
4. Engineered D2R Variants Reveal the Balanced and Biased Contributions of G-Protein and β-Arrestin to Dopamine-Dependent Functions.
Rose SJ; Pack TF; Peterson SM; Payne K; Borrelli E; Caron MG
Neuropsychopharmacology; 2018 Apr; 43(5):1164-1173. PubMed ID: 29068002
[TBL] [Abstract][Full Text] [Related]
5. Molecular determinants of biased agonism at the dopamine D₂ receptor.
Weichert D; Banerjee A; Hiller C; Kling RC; Hübner H; Gmeiner P
J Med Chem; 2015 Mar; 58(6):2703-17. PubMed ID: 25734236
[TBL] [Abstract][Full Text] [Related]
6. Distinct cortical and striatal actions of a β-arrestin-biased dopamine D2 receptor ligand reveal unique antipsychotic-like properties.
Urs NM; Gee SM; Pack TF; McCorvy JD; Evron T; Snyder JC; Yang X; Rodriguiz RM; Borrelli E; Wetsel WC; Jin J; Roth BL; O'Donnell P; Caron MG
Proc Natl Acad Sci U S A; 2016 Dec; 113(50):E8178-E8186. PubMed ID: 27911814
[TBL] [Abstract][Full Text] [Related]
7. Antagonism of dopamine D2 receptor/beta-arrestin 2 interaction is a common property of clinically effective antipsychotics.
Masri B; Salahpour A; Didriksen M; Ghisi V; Beaulieu JM; Gainetdinov RR; Caron MG
Proc Natl Acad Sci U S A; 2008 Sep; 105(36):13656-61. PubMed ID: 18768802
[TBL] [Abstract][Full Text] [Related]
8. Structure-Functional Selectivity Relationship Studies on A-86929 Analogs and Small Aryl Fragments toward the Discovery of Biased Dopamine D1 Receptor Agonists.
Li H; Mirabel R; Zimmerman J; Ghiviriga I; Phidd DK; Horenstein N; Urs NM
ACS Chem Neurosci; 2022 Jun; 13(12):1818-1831. PubMed ID: 35658399
[TBL] [Abstract][Full Text] [Related]
9. A structural basis for how ligand binding site changes can allosterically regulate GPCR signaling and engender functional selectivity.
Sanchez-Soto M; Verma RK; Willette BKA; Gonye EC; Moore AM; Moritz AE; Boateng CA; Yano H; Free RB; Shi L; Sibley DR
Sci Signal; 2020 Feb; 13(617):. PubMed ID: 32019899
[TBL] [Abstract][Full Text] [Related]
10. Effects of β-Arrestin-Biased Dopamine D2 Receptor Ligands on Schizophrenia-Like Behavior in Hypoglutamatergic Mice.
Park SM; Chen M; Schmerberg CM; Dulman RS; Rodriguiz RM; Caron MG; Jin J; Wetsel WC
Neuropsychopharmacology; 2016 Feb; 41(3):704-15. PubMed ID: 26129680
[TBL] [Abstract][Full Text] [Related]
11. Intramolecular allosteric communication in dopamine D2 receptor revealed by evolutionary amino acid covariation.
Sung YM; Wilkins AD; Rodriguez GJ; Wensel TG; Lichtarge O
Proc Natl Acad Sci U S A; 2016 Mar; 113(13):3539-44. PubMed ID: 26979958
[TBL] [Abstract][Full Text] [Related]
12. Ubiquitination of GRK2 Is Required for the β-Arrestin-Biased Signaling Pathway of Dopamine D2 Receptors to Activate ERK Kinases.
Liu H; Ma H; Zeng X; Wu C; Acharya S; Sudan SK; Zhang X
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373182
[TBL] [Abstract][Full Text] [Related]
13. Phosphoproteomic Analysis of Dopamine D2 Receptor Signaling Reveals Interplay of G Protein- and β-Arrestin-Mediated Effects.
Wenk D; Khan S; Ignatchenko V; Hübner H; Gmeiner P; Weikert D; Pischetsrieder M; Kislinger T
J Proteome Res; 2023 Jan; 22(1):259-271. PubMed ID: 36508580
[TBL] [Abstract][Full Text] [Related]
14. Identification of G protein-biased agonists that fail to recruit β-arrestin or promote internalization of the D1 dopamine receptor.
Conroy JL; Free RB; Sibley DR
ACS Chem Neurosci; 2015 Apr; 6(4):681-92. PubMed ID: 25660762
[TBL] [Abstract][Full Text] [Related]
15. Discovery and characterization of a G protein-biased agonist that inhibits β-arrestin recruitment to the D2 dopamine receptor.
Free RB; Chun LS; Moritz AE; Miller BN; Doyle TB; Conroy JL; Padron A; Meade JA; Xiao J; Hu X; Dulcey AE; Han Y; Duan L; Titus S; Bryant-Genevier M; Barnaeva E; Ferrer M; Javitch JA; Beuming T; Shi L; Southall NT; Marugan JJ; Sibley DR
Mol Pharmacol; 2014 Jul; 86(1):96-105. PubMed ID: 24755247
[TBL] [Abstract][Full Text] [Related]
16. RalA employs GRK2 and β-arrestins for the filamin A-mediated regulation of trafficking and signaling of dopamine D2 and D3 receptor.
Zheng M; Zhang X; Sun N; Min C; Zhang X; Kim KM
Biochim Biophys Acta; 2016 Aug; 1863(8):2072-83. PubMed ID: 27188791
[TBL] [Abstract][Full Text] [Related]
17. Trace amine-associated receptor 1 activation silences GSK3β signaling of TAAR1 and D2R heteromers.
Harmeier A; Obermueller S; Meyer CA; Revel FG; Buchy D; Chaboz S; Dernick G; Wettstein JG; Iglesias A; Rolink A; Bettler B; Hoener MC
Eur Neuropsychopharmacol; 2015 Nov; 25(11):2049-61. PubMed ID: 26372541
[TBL] [Abstract][Full Text] [Related]
18. Molecular dynamics simulation of biased agonists at the dopamine D2 receptor suggests the mechanism of receptor functional selectivity.
Montgomery D; Campbell A; Sullivan HJ; Wu C
J Biomol Struct Dyn; 2019 Aug; 37(12):3206-3225. PubMed ID: 30124143
[TBL] [Abstract][Full Text] [Related]
19. Bias analyses of preclinical and clinical D2 dopamine ligands: studies with immediate and complex signaling pathways.
Brust TF; Hayes MP; Roman DL; Burris KD; Watts VJ
J Pharmacol Exp Ther; 2015 Mar; 352(3):480-93. PubMed ID: 25539635
[TBL] [Abstract][Full Text] [Related]
20. G protein beta 5 is targeted to D2-dopamine receptor-containing biochemical compartments and blocks dopamine-dependent receptor internalization.
Octeau JC; Schrader JM; Masuho I; Sharma M; Aiudi C; Chen CK; Kovoor A; Celver J
PLoS One; 2014; 9(8):e105791. PubMed ID: 25162404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
